Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    50,145.82
    -1,222.51 (-2.38%)
     
  • CMC Crypto 200

    1,314.30
    -82.23 (-5.90%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

Top Ranked Momentum Stocks to Buy for June 5th

Akamai Technologies, Inc. (AKAM): This provider of cloud services has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 17.4% over the last 60 days.

Akamai’s shares gained 8.3% over the last one month more than S&P 500’s gain of 2.8%. The company possesses a Momentum Score of A.

Akamai Technologies, Inc. Price and Consensus

Akamai Technologies, Inc. Price and Consensus
Akamai Technologies, Inc. Price and Consensus

Akamai Technologies, Inc. price-consensus-chart | Akamai Technologies, Inc. Quote

AcelRx Pharmaceuticals, Inc. (ACRX): This operator of a specialty pharmaceutical companyhas a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 17.4% over the last 60 days.

ADVERTISEMENT

Akamai Technologies, Inc. Price

Akamai Technologies, Inc. Price
Akamai Technologies, Inc. Price

Akamai Technologies, Inc. price | Akamai Technologies, Inc. Quote

AcelRx’s shares gained 34% over the last one month. The company possesses a Momentum Score of B.

AcelRx Pharmaceuticals, Inc. Price and Consensus

AcelRx Pharmaceuticals, Inc. Price and Consensus
AcelRx Pharmaceuticals, Inc. Price and Consensus

AcelRx Pharmaceuticals, Inc. price-consensus-chart | AcelRx Pharmaceuticals, Inc. Quote

Allied Motion Technologies, Inc. (AMOT): This operator and developer of pipelines and other midstream assets has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 17.9% over the last 60 days.

AcelRx Pharmaceuticals, Inc. Price

AcelRx Pharmaceuticals, Inc. Price
AcelRx Pharmaceuticals, Inc. Price

AcelRx Pharmaceuticals, Inc. price | AcelRx Pharmaceuticals, Inc. Quote

Allied Motion’s shares gained 4.2% over the last one month. The company possesses a Momentum Score of B.

Allied Motion Technologies, Inc. Price and Consensus

Allied Motion Technologies, Inc. Price and Consensus
Allied Motion Technologies, Inc. Price and Consensus

Allied Motion Technologies, Inc. price-consensus-chart | Allied Motion Technologies, Inc. Quote

Allied Motion Technologies, Inc. Price

Allied Motion Technologies, Inc. Price
Allied Motion Technologies, Inc. Price

Allied Motion Technologies, Inc. price | Allied Motion Technologies, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Allied Motion Technologies, Inc. (AMOT) : Free Stock Analysis Report
 
Akamai Technologies, Inc. (AKAM) : Free Stock Analysis Report
 
AcelRx Pharmaceuticals, Inc. (ACRX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.